Detailed price information for Tenon Medical Inc (TNON-Q) from The Globe and Mail including charting and trades.
~Newly issued patents continue to solidify the company's position as an innovator in the rapidly growing sacro-pelvic fusion market~~Portfolio now includes 38 issued U. patents and 9 international patents, with 31 applications pending~~Company anticipates continued additions to its IP portfolio along with several product launches in the coming quarters~LOS GATOS, CA / ACCESS Newswire / October 15, 2026 / , Inc.
~ SImmetry+ System generated approximately $1.2 million in incremental revenue during limited launch period ~~ Company plans to support anticipated demand for the SImmetry+ System by expanding its instrument set inventory as needed ~~ New SImmetry+ 3D printed screw is the first component of a next-generation lateral SI joint fusion system, and the first of several Company product launches expected in the coming quarters ~LOS GATOS, CA / ACCESS Newswire / September 30, 2026 / , Inc.
Detailed price information for Tenon Medical Inc (TNON-Q) from The Globe and Mail including charting and trades.
LOS GATOS, CA / ACCESS Newswire / September 11, 2026 / , Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a medical device company dedicated to transforming care for patients with certain sacro-pelvic disorders announced today it has entered into warrant exercise agreements with an institutional investor to exercise outstanding warrants to purchase an aggregate of 572,179 of the Company's shares of common stock (the "Existing Warrants").
Detailed price information for Tenon Medical Inc (TNON-Q) from The Globe and Mail including charting and trades.
~ Company Takes Proactive Step to Strengthen Balance Sheet and Maintain Flexibility to Execute on Continued Business Momentum ~LOS GATOS, CA / ACCESS Newswire / September 9, 2026 / , Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a medical device company dedicated to transforming care for patients with certain sacro-pelvic disorders, today announced that it has repaid in full its outstanding original issue discount senior convertible promissory notes (the "Notes"), which were issued with an aggr
LOS GATOS, CA / ACCESS Newswire / August 31, 2026 / , Inc. (Nasdaq:TNON), a medical device company dedicated to transforming care for patients with certain sacro-pelvic disorders, has closed its previously announced private placement pursuant to securities purchase agreement with an institutional investor to sell 597,610 shares of common stock (or pre-funded warrants in lieu thereof), together with a warrant to purchase up to an aggregate 1,058,517 shares of common stock, in a private placement
Tipranks Press Release.
LOS GATOS, CA / ACCESS Newswire / August 24, 2026 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a medical device company dedicated to transforming care for patients with certain sacro-pelvic disorders, today announced that it has received notice from The Nasdaq Stock Market LLC ("Nasdaq") confirming that the Company has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) (the "Bid Price Rule"). On February 25, 2026, the Company received a letter from the Listing Qualifications staff of Nasdaq (the "Staff") notifying it that, for the prior 30 consecutive business days, the closing bid price of the Company's common stock had been below the $1.00 per share minimum required under the Bid Price Rule.
Tenon Medical (TNON) said Monday it received notice from Nasdaq confirming the company has regained
Detailed price information for Tenon Medical Inc (TNON-Q) from The Globe and Mail including charting and trades.
This is the newest page. Registered accounts read further back.